Arca
Skip to content
Tools
Tools

Axsym Holo TC Reagent Kit, Model 3L83-20 and 2 more

Radioassay, Vitamin B12. 510(k) K062467, from Axis-Shield Diagnostics, Ltd. (Dundee, GB). Product code CDD, class 2.

As of Nov 18, 2026, K062467 is an FDA 510(k) held by Axis-Shield Diagnostics, Ltd., substantially equivalent on Nov 22, 2006 after 90 days, with no recalls tied to it in FDA's recall database.

  • Review time: 90 days
  • Recalls: 0
  • Cited as a predicate by: 1 device

Indications for use

As the 510(k) summary states them, read from FDA's summary PDF

Reagents AxSYM HoloTC assay is a Microparticle Enzyme Immunoassay (MEIA) for the quantitative determination of holotranscobalamin (vitamin B12 bound to transcobalamin) in human serum and plasma on the AxSYM System. HoloTC is used as an aid in the diagnosis and treatment of vitamin B12 deficiency.

Cited as a predicate

1 later 510(k) summary names this device as a predicate

Other CDD clearances

The newest 510(k)s for the same product code; see every CDD device

Record

Type
Traditional
Received
Aug 24, 2006
Review panel
Clinical Chemistry
Regulation
21 CFR 862.1810

One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files

Logos are each company's own site icon, matched by name through Wikidata, or logos provided by Logo.dev.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.